Richard Valicenti, M.D., M.A., F.A.S.T.R.O.

Richard K. Valicenti, M.D., M.A., F.A.S.T.R.O.

Specialties

Prostate Cancer

Department

Radiation Oncology

Title

  • Professor, Department of Radiation Oncology

Reviews

To see if Richard K. Valicenti is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

UC Davis Comprehensive Cancer Center

4501 X St., G-140
Sacramento, CA 95817
Driving Directions

Primary Phone:
800-362-5566

Additional Phone Numbers

Clinic Phone: 916-734-5820
Clinic Fax: 916-703-5069
Clinic Referral Phone: 916-734-5810
Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Philosophy of Care

Dr. Valicenti believes in being tough on cancer, using a multi-disciplinary team approach and leading therapeutic weapons to maximize outcomes while preventing side effects. He emphasizes that innovation is critical to the advancement of new cancer treatments and that education is essential for the benefit of patients, families and the next generation of cancer caregivers.

Clinical Interests

Dr. Valicenti is nationally and internationally recognized in the treatment of prostate cancer and other tumors. His clinical interests focus on prostate cancer, gynecologic tumors, genitourinary malignancies and brain tumors. His expertise and offers service for prostate seed implantation, HDR prostate, SBRT, and image-guided IMRT and Gamma Knife for cancer treatment.

Research/Academic Interests

Dr. Valicenti is conducting clinical research to evaluate multi-modality therapies for clinically localized prostate cancer. In addition, he is carrying out outcome-based studies addressing quality-of-life questions and exploratory analyses of large databases.

Division

Radiation Oncology

Center/Program Affiliation

UC Davis Comprehensive Cancer Center

Education

M.D., Drexel University College of Medicine, Philadelphia PA 1990

M.A., Columbia University Graduate School, New York NY 1984

B.S., Massachusetts Institute of Technology (MIT), Cambridge MA 1981

Internship: Internal Medicine, Hahneman Hospital, Philadelphia PA 1991

Residency

Radiation Oncology, Washington University School of Medicine, St. Louis MO 1995

Fellowships

Radiation Oncology, Washington University School of Medicine, St. Louis MO 1995

Board Certifications

American Board of Radiology, Radiation Oncology, 2016

Professional Memberships

American Brachytherapy Society

American Society of Therapeutic Radiology and Oncology

Honors and Awards

Best Doctors in America, Radiation Oncology, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013

Resident Travel Award, American Society of Therapeutic Radiology and Oncology (Faculty Advisor), 2006

Sigma Xi Award for Medical Student Research (Faculty Advisor), 2006

Resident Clinical Research Award, American Society of Therapeutic Radiology and Oncology (Faculty Advisor), 2003

Marquis Who's Who in Medicine, 2002

Philadelphia Magazine, Best Docs, Radiation Oncology, 2002

Select Recent Publications

Rash DL, Lee YC, Kashefi A, Durbin-Johnson B, Mathai M, Valicenti R, Mayadev JS. Clinical response of pelvic and para-aortic lymphadenopathy to a radiation boost in the definitive management of locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):317-22. doi:10.1016/j.ijrobp.2013.06.2031. Epub 2013 Jul 29.

Lim J, Durbin-Johnson B, Valicenti R, Mathai M, Stern RL, Mayadev J. The impact of maximum rectal distention and tandem angle on rectal dose delivered in 3D planned gynecologic high dose-rate brachytherapy. Int J Gynecol Cancer. 2013 Jul;23(6):1078-83. doi:10.1097/IGC.0b013e3182959030.

Rash D, Hagar Y, Cui J, Hunt JP, Valicenti R, Mayadev J. Interfraction motion of the vaginal apex during postoperative intensity modulated radiation therapy: are we missing the target? Int J Gynecol Cancer. 2013 Feb;23(2):385-92. doi:10.1097/IGC.0b013e3182791f24.

Kunos CA, Winter K, Dicker AP, Small W, Abdul-Karim FW, Dawson D, Jhingran A, Valicenti R, Weidhaas JB, Gaffney DK. Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis. Int J Gynecol Cancer. 2013 May;23(4):615-21. doi:10.1097/IGC.0b013e31828b4eb5.

Lim J, Durbin-Johnson B, Valicenti R, Mathai M, Stern RL, Mayadev J. The impact of body mass index on rectal dose in locally advanced cervical cancer treated with high-dose-rate brachytherapy. Brachytherapy. 2013 Nov-Dec;12(6):550-4.  doi:10.1016/j.brachy.2013.04.006. Epub 2013 May 23.

Valicenti RK, Thompson I, Albertsen P, Davis BJ, Goldenberg SL, Wolf JS, Sartor O, Klein E, Hahn C, Michalski J, Roach M, Faraday MM. Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines. (ASTRO/AUA Joint Approved Publication). Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):822-8. doi:10.1016/j.ijrobp.2013.05.029.

Thompson IM, Valicenti RK, Albertsen P, Davis BJ, Goldenberg SL, Hahn C, Klein E, Michalski J, Roach M, Sartor O, Wolf JS, Faraday MM. Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline. (ASTRO/AUA Joint Approved Publication). J Urol. 2013 Aug;190(2):441-9. doi:10.1016/j.juro.2013.05.032. Epub 2013 May 21.

Greene DE, Mayadev JS, Valicenti RK. Radiation treatment for patients with intermediate-risk prostate cancer. Ther Adv Urol. 2012 Jun;4(3):113-24. doi:10.1177/1756287212442977.

Michalski J, Winter K, Roach M, Markoe A, Sandler HM, Ryu J, Parliament M, Purdy JA, Valicenti RK, Cox JD. Clinical Outcome of Patients Treated With 3D Conformal Radiation Therapy (3D-CRT) for Prostate Cancer on RTOG 9406. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):e363-70. doi:10.1016/j.ijrobp.2011.12.070.

Perks JR, Stanic S, Stern RL, Henk B, Nelson MS, Harse RD, Mathai M, Purdy JA, Valicenti RK, Siefkin AD, Chen AM. Failure Mode and Effect Analysis for Delivery of Lung Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1324-9. doi:10.1016/j.ijrobp.2011.09.019. Epub 2011 Dec 22.